Viewing Study NCT02086227


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-02-10 @ 2:13 PM
Study NCT ID: NCT02086227
Status: COMPLETED
Last Update Posted: 2014-03-13
First Post: 2014-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
Sponsor: Fresenius Kabi USA, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-05
Start Date Type: None
Primary Completion Date: 2013-06
Primary Completion Date Type: ACTUAL
Completion Date: 2013-06
Completion Date Type: ACTUAL
First Submit Date: 2014-03-11
First Submit QC Date: None
Study First Post Date: 2014-03-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-03-12
Last Update Post Date: 2014-03-13
Last Update Post Date Type: ESTIMATED